Kura Oncology Inc
For the period ended Dec 31, 2024. Filed Feb 28, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2024 · Filed Feb 28, 2025
KURA$7.57+4.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets
(In thousands, except par value data)
| December 31, | ||
|---|---|---|
| 2024 | 2023 | |
| Assets | ||
| Current assets | ||
| Cash and cash equivalents | $224,462 | $37,318 |
| Short-term investments | 502,933 | 386,639 |
| Prepaid expenses and other current assets | 17,434 | 8,524 |
| Total current assets | 744,829 | 432,481 |
| Property and equipment, net | 1,682 | 1,859 |
| Operating lease right-of-use assets | 5,803 | 6,993 |
| Other long-term assets | 7,845 | 7,602 |
| Total assets | $760,159 | $448,935 |
| Liabilities and Stockholders’ Equity | ||
| Current liabilities | ||
| Accounts payable and accrued expenses | $49,953 | $33,757 |
| Current operating lease liabilities | 1,881 | 1,506 |
| Current portion of long-term debt | 2,607 | — |
| Current portion of contract liabilities | 24,271 | — |
| Total current liabilities | 78,712 | 35,263 |
| Long-term debt, net of current portion | 6,916 | 9,332 |
| Long-term operating lease liabilities | 5,190 | 6,362 |
| Other long-term liabilities | 1,795 | 705 |
| Long-term contract liabilities | 253,906 | — |
| Total liabilities | 346,519 | 51,662 |
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value; 10,000 shares authorized; no shares issued and outstanding | — | — |
| Common stock, $0.0001 par value; 200,000 shares authorized; 78,229 and 74,350 shares issued and outstanding as of December 31, 2024 and 2023, respectively | 8 | 7 |
| Additional paid-in capital | 1,308,290 | 1,119,976 |
| Accumulated other comprehensive income (loss) | 764 | (1,271) |
| Accumulated deficit | (895,422) | (721,439) |
| Total stockholders’ equity | 413,640 | 397,273 |
| Total liabilities and stockholders’ equity | $760,159 | $448,935 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.